Related Experiment Videos
[Labelling meproscillarin with tritium at the C-19 position (author's transl)]
Arzneimittel-Forschung
|January 1, 1978
Summary
This study describes the successful labeling of meproscillarin, a bufadienolide, using deuterium and tritium. The isotopes were precisely introduced at the metabolically stable C-19 position for advanced research applications.
Area of Science:
- Organic Chemistry
- Isotope Chemistry
- Pharmacology
Context:
- Bufadienolides are a class of cardiac glycosides with significant pharmacological properties.
- Meproscillarin is a specific bufadienolide derivative.
- Stable isotope labeling is crucial for metabolic and pharmacokinetic studies.
Purpose:
- To develop a method for labeling meproscillarin with stable isotopes (deuterium and tritium).
- To introduce these isotopes at the metabolically stable C-19 position of the bufadienolide structure.
Summary:
- The research details the successful synthesis of deuterium- and tritium-labeled meproscillarin.
- The labeling strategy specifically targets the C-19 position, known for its metabolic stability.
- This facilitates the tracking and analysis of meproscillarin in biological systems.
Impact:
- Provides researchers with isotopically labeled meproscillarin for advanced drug metabolism and pharmacokinetic studies.
- Enables more accurate quantification and understanding of meproscillarin's fate in vivo.
- Supports the development and clinical evaluation of bufadienolide-based therapeutics.